Literature DB >> 15231847

A novel mode of action of an ArfGAP, AMAP2/PAG3/Papa lpha, in Arf6 function.

Shigeru Hashimoto1, Ari Hashimoto, Atsuko Yamada, Chie Kojima, Hiroko Yamamoto, Tomonari Tsutsumi, Mikito Higashi, Akira Mizoguchi, Ryohei Yagi, Hisataka Sabe.   

Abstract

Previously we reported that AMAP2/PAG3/Papalpha/KIAA0400, a GTPase-activating protein (GAP), acts to antagonize Arf6 function when overexpressed, whereas it was shown to exhibit efficient GAP activities for other Arf isoforms in vitro. Here, we found that AMAP2, through its ArfGAP domain, binds to GTP-Arf6 but not to GDP-Arf6 or other Arfs irrespective of nucleotide status. The majority of AMAP2 was localized to intracellular tubulovesicular structures and redistributed to Arf6-enriched membrane areas upon Arf6 activation. In HeLa cells, Arf6 has been shown to be involved in the clathrin-independent endocytosis of Tac, but not the clathrin-dependent endocytosis of transferrin. We found that Arf6 silencing inhibited the internalization of Tac, but not transferrin, in HeLa cells. Internalization of Tac, but not transferrin, was also significantly inhibited by AMAP2 silencing and overexpression. AMAP2 was moreover found to bind to amphiphysin IIm, a component of the endocytic machinery, via its proline-rich domain. We propose that AMAP2 has dual mechanisms for its function; it exhibits efficient catalytic GAP activity for the class I and II Arfs and yet is involved in the cellular function of the class III Arf without immediate GAP activity. These dual mechanisms of AMAP2 may be important for the cellular function of GTP-Arf6.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15231847     DOI: 10.1074/jbc.M404196200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis.

Authors:  Shigeru Hashimoto; Mayumi Hirose; Ari Hashimoto; Masaki Morishige; Atsuko Yamada; Harumi Hosaka; Ken-ichi Akagi; Eiji Ogawa; Chitose Oneyama; Tsutomu Agatsuma; Masato Okada; Hidenori Kobayashi; Hiromi Wada; Hirofumi Nakano; Takahisa Ikegami; Atsushi Nakagawa; Hisataka Sabe
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

Review 2.  Regulation of actin cytoskeleton dynamics by Arf-family GTPases.

Authors:  Kenneth R Myers; James E Casanova
Journal:  Trends Cell Biol       Date:  2008-03-06       Impact factor: 20.808

Review 3.  The PIX-GIT complex: a G protein signaling cassette in control of cell shape.

Authors:  Scott R Frank; Steen H Hansen
Journal:  Semin Cell Dev Biol       Date:  2008-01-20       Impact factor: 7.727

4.  Arf GTPase-activating protein ASAP1 interacts with Rab11 effector FIP3 and regulates pericentrosomal localization of transferrin receptor-positive recycling endosome.

Authors:  Hiroki Inoue; Vi Luan Ha; Rytis Prekeris; Paul A Randazzo
Journal:  Mol Biol Cell       Date:  2008-08-06       Impact factor: 4.138

5.  Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities.

Authors:  Yasuhito Onodera; Shigeru Hashimoto; Ari Hashimoto; Masaki Morishige; Yuichi Mazaki; Atsuko Yamada; Eiji Ogawa; Masashi Adachi; Takaki Sakurai; Toshiaki Manabe; Hiromi Wada; Nariaki Matsuura; Hisataka Sabe
Journal:  EMBO J       Date:  2005-02-17       Impact factor: 11.598

6.  Putative terminator and/or effector functions of Arf GAPs in the trafficking of clathrin-coated vesicles.

Authors:  Shunsuke Kon; Tomo Funaki; Masanobu Satake
Journal:  Cell Logist       Date:  2011-05

7.  Selenoprotein K regulation of palmitoylation and calpain cleavage of ASAP2 is required for efficient FcγR-mediated phagocytosis.

Authors:  Robert L Norton; Gregory J Fredericks; Zhi Huang; Jeffrey D Fay; FuKun W Hoffmann; Peter R Hoffmann
Journal:  J Leukoc Biol       Date:  2016-09-06       Impact factor: 4.962

Review 8.  Arf GAPs: gatekeepers of vesicle generation.

Authors:  Anne Spang; Yoko Shiba; Paul A Randazzo
Journal:  FEBS Lett       Date:  2010-04-13       Impact factor: 4.124

9.  Regulation of Bin1 SH3 domain binding by phosphoinositides.

Authors:  Chie Kojima; Ari Hashimoto; Izumi Yabuta; Mayumi Hirose; Shigeru Hashimoto; Yasunori Kanaho; Hideki Sumimoto; Takahisa Ikegami; Hisataka Sabe
Journal:  EMBO J       Date:  2004-10-14       Impact factor: 11.598

Review 10.  The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis.

Authors:  Hisataka Sabe; Shigeru Hashimoto; Masaki Morishige; Eiji Ogawa; Ari Hashimoto; Jin-Min Nam; Koichi Miura; Hajime Yano; Yasuhito Onodera
Journal:  Traffic       Date:  2009-04-21       Impact factor: 6.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.